Petros Pharmaceuticals Faces Default Event, Forced Partial Repayment of Obligations
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) encountered a default event, necessitating immediate repayment of outstanding obligations. As outlined in a recent 8-K filing with the Securities and Exchange Commission dated December 10, 2024, the company’s subsidiary, Metuchen Pharmaceuticals LLC, defaulted on a payment due on October 1, 2024, which triggered the acceleration of obligations. The default event […]
More Stories
Insider Selling: HP Inc. (NYSE:HPQ) Insider Sells 74,356 Shares of Stock
HP Inc. (NYSE:HPQ – Get Free Report) insider Kristen M. Ludgate sold 74,356 shares of the firm’s stock in a...
CTT – Correios De Portugal (OTCMKTS:CTTPY) Hits New 1-Year High – Time to Buy?
CTT – Correios De Portugal, S.A. (OTCMKTS:CTTPY – Get Free Report)’s share price reached a new 52-week high on Monday...
SoFi Technologies, Inc. (NASDAQ:SOFI) EVP Purchases $500,004.00 in Stock
SoFi Technologies, Inc. (NASDAQ:SOFI – Get Free Report) EVP Eric Schuppenhauer bought 30,600 shares of SoFi Technologies stock in a...
CSW Industrials, Inc. (NASDAQ:CSWI) EVP Don Sullivan Sells 1,965 Shares
CSW Industrials, Inc. (NASDAQ:CSWI – Get Free Report) EVP Don Sullivan sold 1,965 shares of CSW Industrials stock in a...
Joseph Evan Calio Buys 50,000 Shares of FREYR Battery, Inc. (NYSE:FREY) Stock
FREYR Battery, Inc. (NYSE:FREY – Get Free Report) CFO Joseph Evan Calio acquired 50,000 shares of the company’s stock in...
Willdan Group, Inc. (NASDAQ:WLDN) Director Thomas Donald Brisbin Sells 7,700 Shares of Stock
Willdan Group, Inc. (NASDAQ:WLDN – Get Free Report) Director Thomas Donald Brisbin sold 7,700 shares of Willdan Group stock in...